Glamyo Health targets USD 100 million ARR in 2022-23

New Delhi: Glamyo Health, an asset light healthcare startup operating in the field of elective surgeries has announced closing the fiscal 2021-22 with an Annual recurring revenue (ARR) of USD 8 mn. The brand aims at closing the new fiscal 2022-23 with an ARR USD 100 mn.

Glamyo Health is a multi-specialty healthcare brand which delivers hassle-free experience for all types of cosmetic procedures and elective surgeries with personalized care.

The healthcare startup has reached a mark of 400 surgical centers across 26,000 pin codes, adding at least 50-60 centers on an average every quarter. Through aggressive expansion Glamyo Health has been able to penetrate across 16 metropolises in India including – Delhi, Mumbai, Hyderabad, Bangalore, Pune, Chandigarh, Indore, Bhubaneshwar, Patna, Mysore, Madurai, Chennai, Ahmedabad, Nagpur, Lucknow, Kochi, Coimbatore.

“We have been able to record a month-on-month growth of 25% in terms of revenue. Our aggressive expansion has ensured availability and service. Additionally, we are maintaining a fine customer service and treatments which together have helped us scale rapidly,” said Archit Garg, Co-founder at Glamyo Health.

“We identified the areas where the traditional healthcare system has not served enough. Further, we ensure that we do not just fill the gap, but we fill it with the best in class cutting edge treatment modalities. We shall continue to expand our portfolio of offerings and strive for 100% patient satisfaction. We plan to source some unique technologies from different parts of the world and introduce them in India to bring the industry at par with the global standards,”  said Dr. Preet Pal Thakur, Co-Founder, Glamyo Health.

In the last one year the brand has already made key global surgical technologies available, including minimally invasive elective and cosmetic surgeries, including Laser proctology treatments, Laparoscopic surgeries, and Circumcision.